by Richard Daverman, PhD
September 27, 2013 -- Boehringer Ingelheim has completed a $95 million expansion of its Shanghai production facility, a process that included moving the company’s China Center of Excellence from Waigaojiao to the Shanghai site. The Center of Excellence optimizes the vetting process for the APIs and intermediates that BI sources from its China partners. The site, located in Zhangjiang Hi-Tech Park, will also be the home for BI’s $81 million biologics contract manufacturing operation announced in June. More details....
Help employers find you! Check out all the jobs and post your resume.
